What does a three-month plan actually cost at VevaRX?

That depends which part of the page you read, which is the problem. On the sermorelin page: a hero block says "$399 total, equivalent to $133 per month", a panel headed Important Plan Information says "the three-month plan is priced at $367", and a card lower down says "$467 total, equivalent to $155.67/month". The NAD+ page does the same with $399, $447 and $467, and glutathione with $349, $267 and $467. The site does not say which is charged. The month-to-month figure is consistent at $167 across all three products, so that is the number we carry.

How do we know the price blocks are copy-paste errors rather than tiers?

Because one of them names the wrong product's figure. The NAD+ page's billing line reads "$267 includes full treatment, supplies, and provider visit" — but $267 is the number stated on the glutathione page, not the NAD+ page, which elsewhere says $447. Similarly, the semaglutide page's Program Details paragraph quotes $167/month and $467 for three months, which are the sermorelin, NAD+ and glutathione figures rather than semaglutide's own $189 and $399. These are the same template blocks reused across products without the numbers being updated.

Which pharmacy fills VevaRX prescriptions?

Strive Pharmacy, named in the privacy policy alongside TelegraMD as the parties your information is disclosed to. Strive is a 503A compounding pharmacy that also fills for EdgeRx. Naming both the telehealth vendor and the pharmacy is a real disclosure and puts VevaRX ahead of many sellers — AHBARx, Andrew Meds, Bayan Health, RENN Health and others never name a pharmacy at all. It makes the pricing confusion more frustrating rather than less.

What does tirzepatide cost?

Its tirzepatide page shows no pricing cards at all. The page describes the product, carries the compounded-status disclosure and explains the assessment process, but no monthly or plan price appears on it. Semaglutide is priced at $189/month or $399 for three months, so tirzepatide would normally sit above that, but ask for the figure before you start an assessment.

Is there a minimum commitment?

On the longevity line, yes. The plan panels state a three-month minimum with the plan billed every three months and renewing automatically, cancellable at any time, and note that a provider review may be required after three months. So sermorelin, NAD+ and glutathione are quarterly commitments even where a monthly figure is shown. The $167 monthly option is presented as the alternative to that, which is the cleanest way to buy here given the confusion around the quarterly figures.

Is VevaRX expensive compared with other GLP-1 telehealth providers?

VevaRX publishes a starting figure of $189/mo. Across the 112 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $399 with a median of $179, which puts VevaRX above the median. The other 173 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Updated September 2026

VevaRX review

Discloses well, prices badly

Names its pharmacy and telehealth vendor, states the compounded warning seventeen times — and quotes one plan three different ways.

Our verdict

VevaRX pulls hard in two directions. Its disclosure is strong: its privacy policy names TelegraMD and Strive Pharmacy — the same 503A pharmacy EdgeRx uses — as the parties your data goes to, it displays a LegitScript seal with a checkable ID, and it states that compounded medications are not FDA-approved seventeen times. Its pricing is its weakest point. Every longevity product page quotes the same three-month plan three different ways: sermorelin appears as $399, $367 and $467 on one page; NAD+ as $399, $447 and $467; glutathione as $349, $267 and $467. The NAD+ page's billing line even quotes $267, which is glutathione's figure. The one consistent number is the $167 monthly rate. Buy here for the named supply chain, and confirm the charge before you subscribe.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Check availability →Semaglutide $189/mo or $399 per 3 months ($133/mo); its own page text quotes different figures

At a glance

Category: GLP-1 telehealth
Access: Semaglutide $189/mo or $399 per 3 months ($133/mo); its own page text quotes different figures
Medications: Compounded semaglutide · Compounded tirzepatide
Insurance: Cash-pay, no insurance
Visit: Quiz intake / Async intake
Availability: 50 states
LegitScript: Claimed by provider

Partner alternative

Enhance MD

Lab-guided treatment under ongoing physician oversight

Check Enhance MD availability →

What it is

A telehealth service operated by VevaRx LLC, selling compounded semaglutide and tirzepatide for weight loss alongside a vitality line of sermorelin, NAD+, glutathione and PT-141. It states 50-state availability and displays a LegitScript seal (ID 49835469).

How it works

Assessment-led and asynchronous: you complete a health assessment for review by a licensed provider, and treatment is available only when prescribed following an appropriate medical evaluation — language the site repeats rather than softens. Its supply-chain disclosure is the standout: the privacy policy states that VEVArx may disclose your information "to TelegraMD, Strive Pharmacy, and Third Party Services", which identifies both the telehealth vendor and the dispensing pharmacy by name. Strive is a 503A pharmacy that also fills for EdgeRx. Delivery is stated as free two-to-three-day shipping.

Pricing transparency

Read this carefully, because VevaRX's product pages contradict themselves. Semaglutide is the cleanest: $189/month on the monthly plan, or $399 total for three months, stated as $133/month. But that page then carries a "Program Details" paragraph reading "choose a monthly program for $167 per month or save with the 3-month program for $467 total" — figures that belong to its other products, left in place unedited. On the longevity line the same three-month plan is quoted three ways on a single page. Sermorelin: a hero block saying "$399 total, equivalent to $133 per month"; a panel headed Important Plan Information saying "the three-month plan is priced at $367"; and a lower card offering "$467 total, equivalent to $155.67/month". NAD+: $399, then $447, then $467 — and its billing line says "$267 includes full treatment", which is glutathione's number. Glutathione: $349, then $267, then $467. PT-141 is the one clean pair at $247/month or $663 for three ($221/month). The month-to-month rate is consistent at $167 across sermorelin, NAD+ and glutathione. Its tirzepatide page shows no pricing at all.

Branded vs compounded

Compounded semaglutide and tirzepatide, plus sermorelin, NAD+, glutathione and PT-141. VevaRX states that compounded medications are not FDA-approved seventeen times across its pages, and adds that compounded tirzepatide may vary in appearance from the product images shown, which is an honest detail most sellers omit. On the evidence: the GLP-1 outcome data belongs to the branded products, not to compounded copies; sermorelin has a genuine growth-hormone-axis mechanism with thin long-term outcome data; injected NAD+ has no controlled human outcome trials, with the randomized evidence on oral NR/NMN precursors; injected glutathione has essentially none for its marketed uses; and PT-141 is FDA-approved only for hypoactive sexual desire disorder in premenopausal women, so use in men is off-label. Because PT-141 is its only sexual-health product and it sells no PDE5 inhibitor, we don't cover VevaRX as an ED provider.

Pros and watch-outs

What we like

Names both the telehealth vendor (TelegraMD) and the dispensing pharmacy (Strive, a 503A facility)
States that compounded medications are not FDA-approved seventeen times across its pages
Discloses that compounded product may differ in appearance from the images shown
Displays a LegitScript seal with a checkable ID
Semaglutide at $189/month, or $399 per three months, is competitively priced

Watch-outs

Each longevity product page quotes the same three-month plan three different ways
The NAD+ page's billing line quotes glutathione's price, proving the blocks are unreconciled
The semaglutide page's Program Details paragraph carries another product's figures
The tirzepatide page shows no pricing at all
Three-month minimums apply on the longevity line, with automatic quarterly renewal

Best for

Readers who want a named 503A pharmacy and heavy compounded-status disclosure, and who will confirm the actual charge before subscribing.

Who should look elsewhere

Anyone who needs to know the price with confidence from the website, or who wants tirzepatide priced before an intake.

The evidence behind what VevaRX prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
Sermorelin benefits: does it work? What the trials show
A real GHRH drug, read against the anti-aging pitch: an approved growth-hormone-releasing analog with a pediatric track record, and a longevity case built more on biomarkers than outcomes.
NAD+ injections: benefits, side effects, cost and what the evidence says
Subcutaneous NAD+ is sold as a cheaper, at-home alternative to the IV drip, through “near me” clinics or telehealth shipped to your door. It’s compounded, not FDA-approved, and has no outcome trials; oral NR/NMN precursors are the route with the human data.
Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
PT-141 (bremelanotide): the evidence on a peptide that is actually FDA-approved
Bremelanotide (Vyleesi) is FDA-approved for HSDD in premenopausal women, with phase-3 trial evidence. A straight read of what's proven — and where off-label use goes beyond it.

How VevaRX compares

A few alternatives worth a look, depending on what you’re optimizing for.

CoreAge Rx
Flat pricing that does not climb as your dose titrates up
See CoreAge Rx →
Oak Longevity
Low-cost compounded GLP-1 bundled with a longevity stack
See Oak Longevity →
Mondae
Buyers who want a low, honest month-to-month price with the compounding source named
See Mondae →

Compare all providers side by side →

More GLP-1 telehealth reviews: Chronos Body Health & WellnessCieloCitizen MedsClayaCLYR HealthCoivas

Nadia Feldman

Access & cost

How we assessed this. This review reflects Aminoscope’s own read of VevaRX’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

What does a three-month plan actually cost at VevaRX?: That depends which part of the page you read, which is the problem. On the sermorelin page: a hero block says "$399 total, equivalent to $133 per month", a panel headed Important Plan Information says "the three-month plan is priced at $367", and a card lower down says "$467 total, equivalent to $155.67/month". The NAD+ page does the same with $399, $447 and $467, and glutathione with $349, $267 and $467. The site does not say which is charged. The month-to-month figure is consistent at $167 across all three products, so that is the number we carry.
How do we know the price blocks are copy-paste errors rather than tiers?: Because one of them names the wrong product's figure. The NAD+ page's billing line reads "$267 includes full treatment, supplies, and provider visit" — but $267 is the number stated on the glutathione page, not the NAD+ page, which elsewhere says $447. Similarly, the semaglutide page's Program Details paragraph quotes $167/month and $467 for three months, which are the sermorelin, NAD+ and glutathione figures rather than semaglutide's own $189 and $399. These are the same template blocks reused across products without the numbers being updated.
Which pharmacy fills VevaRX prescriptions?: Strive Pharmacy, named in the privacy policy alongside TelegraMD as the parties your information is disclosed to. Strive is a 503A compounding pharmacy that also fills for EdgeRx. Naming both the telehealth vendor and the pharmacy is a real disclosure and puts VevaRX ahead of many sellers — AHBARx, Andrew Meds, Bayan Health, RENN Health and others never name a pharmacy at all. It makes the pricing confusion more frustrating rather than less.
What does tirzepatide cost?: Its tirzepatide page shows no pricing cards at all. The page describes the product, carries the compounded-status disclosure and explains the assessment process, but no monthly or plan price appears on it. Semaglutide is priced at $189/month or $399 for three months, so tirzepatide would normally sit above that, but ask for the figure before you start an assessment.
Is there a minimum commitment?: On the longevity line, yes. The plan panels state a three-month minimum with the plan billed every three months and renewing automatically, cancellable at any time, and note that a provider review may be required after three months. So sermorelin, NAD+ and glutathione are quarterly commitments even where a monthly figure is shown. The $167 monthly option is presented as the alternative to that, which is the cleanest way to buy here given the confusion around the quarterly figures.
Is VevaRX legit?: VevaRX is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. Its stated availability: 50 states. What it publishes up front: Semaglutide $189/mo or $399 per 3 months ($133/mo); its own page text quotes different figures. It is cash-pay and states it does not bill insurance. It shows a LegitScript seal. Ask the company for its certificate number before you rely on it. Those are the provider's own published claims rather than checks we could run ourselves, so get the ones that matter to you confirmed in writing before you pay.
Is VevaRX expensive compared with other GLP-1 telehealth providers?: VevaRX publishes a starting figure of $189/mo. Across the 112 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $399 with a median of $179, which puts VevaRX above the median. The other 173 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Check availability →

Or compare every GLP-1 provider.